Herbalife India Congratulates Virat Kohli for Being Appointed as Captain of the Indian Cricket Team for All Formats

Bangalore, India

Ajay Khanna, Vice President and Country Head of Herbalife India, said, “Virat is immensely talented and has demonstrated leadership qualities that led the U19 India team to a World Cup victory. He personifies determination and grit and has demonstrated these traits in all his games. His success with the test team is proof that he will make a great captain that India will be proud of. Herbalife wishes him success and we are confident that he will lead India in the true spirit of sporting excellence and will continue to inspire and motivate others.”

 



Ajay Khanna, Country Head & VP, Herbalife International India Pvt. Ltd. with Virat Kohli - Herbalife India’s sponsored athlete at an event

Comments

Post a Comment

Popular posts from this blog

JCB India launches its new 3DX ecoXPERT

Image
JCB India launches its new 3DX ecoXPERT Designed to give significant savings in Fuel and Maintenance Integrated with “IntelliPerformance” India’s leading manufacturer of Earthmoving and Construction Equipment, JCB India launched its all new 3DX ecoXPERT Backhoe Loader in Bhopal.With JCB’s ‘IntelliPerformance’ technology, which efficiently manages the energy demands of the machine, the intelligent new 3DX ecoXPERT saves fuel and reduces maintenance costs, thus leading to significant savings.Mr. Subir Kumar Chowdhury, Managing Director & CEO of JCB India says, “We are delighted to have launched our new Backhoe Loader, the 3DX ecoXPERT. This new machine is designed to give up to 12% savings on fuel and up to 22% savings on maintenance. Equipped with ‘IntelliPerformance’ technology the machine comes with advanced telematics called JCB Livelink which enables real-time fleet management of equipment for our customers. JCB has pioneered in integrating Smart technologies such as Internet o
Read more

Dr. Reddy’s Laboratories announces the first generic launch , Delayed Release Tablets in the U.S. Market

Image
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo ®  Tablets and to provide an affordable treatment alternative for patients.” The Vimovo ® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*.Dr. Reddy’s Naproxen and Esome
Read more